o The reporting of two (2) or more  independent 5 False Adverse Analytical Finding s per EQAS  round ; or o The reporting of three (3) or more  independent 5 False Adverse Analytical Findings , including EQAS  and routine Analytical Testing , per twelve ( 12)-month  period ; or o The reporting of three (3) or more independent 5 False Negative Findings  per EQAS  round ; or  o The reporting of four (4) or more independent 5 False Negative Findings , including EQAS  and routine Analytical Testing , per twelve (12)-month period ; or o Any combination of four (4)  or more independent 5 False Adverse Analytical Findings  and False Negative Findings , including EQAS  and routine Analytical Testing , per twelve ( 12)-month period.